Hep C - Aethlon Medical Expands Device Pipeline to Include the Treatment of

Aethlon Medical Expands Device Pipeline to Include the Treatment of
Genetic Engineering News - Aethlon Medical plans to combine the core principles of its Hemopurifier platform technology with intellectual property developed by researchers at Boston University as a means to help prevent the spread of cancer following surgery. When cancer has

Tainted-blood case to continue
Globe and Mail - The Crown will push ahead with its case against officials charged in Canada's tainted-blood scandal one of Canada's worst public-health tragedies despite concerns about evidence from key expert witness. The decision came during a brief hearing

Enzo Awarded Patent for Phosphate Labeling for DNA Diagnostic and
Genetic Engineering News - Enzo Biochem, Inc. (NYSE:ENZ) announced today that its subsidiary, Enzo Life Sciences, Inc., has been granted U.S. Patent No. 6,992,180, entitled "Oligo-or polynucleotides comprising phosphate-moiety labeled nucleotides," describing techniques

Peregrine Pharmaceutical Will Deliver Hepatitus C Phase I Safety Data
Medical News Today - Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a biopharmaceutical company with a portfolio of innovative, clinical stage product candidates for viral diseases and cancer, today announced that it has completed planned patient enrollment and dosing

Witness puts blood trial in jeopardy
Biloxi Sun Herald - TORONTO - The case against four physicians and a U.S. pharmaceutical company accused of failing to properly screen blood that infected thousands of Canadians with HIV and hepatitis was in jeopardy Monday after a key witness cast doubt on some